FTRE
Fortrea Holdings Inc. NASDAQ Listed Jun 20, 2023$15.31
-0.07%
vs $15.32
Mkt Cap $1.4B
52w Low $4.45
77.8% of range
52w High $18.40
50d MA $13.41
200d MA $12.45
P/E (TTM)
-1.4x
EV/EBITDA
—
P/B
2.5x
Debt/Equity
0.1x
ROE
-175.0%
P/FCF
15.8x
RSI (14)
49.50
ATR (14)
$1.06
Beta
1.77
50d MA
$13.41
200d MA
$12.45
Avg Volume
1.3M
Fortrea Holdings Inc., a contract research organization, primarily engages in the provision of biopharmaceutical product and medical device development services worldwide. It operates through two segments: Clinical Services and Enabling Services. The Clinical Services segment provides across the clinical pharmacology and clinical development spectrum. The Enabling Services segment provides patient access and clinical trial technology solutions to customers that streamline complex randomization and optimize the trial drug supply process. The company offers delivery models that include full service, functional service provider, and hybrid service structures. It also offers phase I-IV clinical trial management, differentiated technology enabled trial solutions, and post approval services. The company serves pharmaceutical, biotechnology, and medical device organizations. Fortrea Holdings Inc. was incorporated in 2023 and is based in Durham, North Carolina.
8 Moore Drive · Durham, NC 27709 · US
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| May 5, 2026 | TNS | 0.03 | 0.16 | +433.3% | 14.53 | +2.2% | +7.6% | -0.4% | -0.9% | -2.9% | -2.5% | — |
| Feb 26, 2026 | TNS | 0.16 | 0.09 | -43.8% | 10.80 | -3.4% | -0.7% | +0.0% | -1.5% | -0.8% | -1.0% | — |
| Nov 5, 2025 | TNS | 0.16 | 0.12 | -25.0% | 11.95 | -0.9% | -7.8% | +0.0% | +2.1% | -0.6% | +5.5% | — |
| Aug 6, 2025 | TNS | 0.06 | 0.19 | +216.7% | 6.58 | +4.6% | +10.0% | +0.0% | -9.1% | -2.9% | +14.4% | — |
| May 12, 2025 | TNS | -0.07 | 0.02 | +128.6% | 5.19 | +1.3% | -3.7% | +0.0% | -4.4% | -0.6% | -6.5% | — |
| Mar 3, 2025 | TNS | 0.36 | 0.18 | -50.0% | 10.38 | -0.8% | +5.6% | +0.0% | -0.6% | -1.8% | -0.1% | — |
| Nov 8, 2024 | TNS | 0.27 | 0.23 | -14.8% | 23.50 | +4.2% | -3.2% | +0.0% | -3.5% | -3.1% | -5.1% | — |
| Aug 12, 2024 | TNS | 0.07 | -0.03 | -142.9% | 20.04 | +0.5% | +10.9% | +0.0% | +4.4% | -3.4% | -0.6% | — |
| May 13, 2024 | TNS | -0.01 | -0.04 | -618.7% | 28.11 | +0.4% | +2.6% | +0.0% | -0.2% | -3.3% | -0.9% | — |
| Mar 11, 2024 | TNS | 0.23 | 0.19 | -17.4% | 36.41 | +0.1% | +4.4% | +0.0% | +2.4% | +0.6% | +0.4% | — |
| Nov 13, 2023 | TNS | 0.18 | 0.24 | +33.3% | 30.92 | +3.4% | +5.0% | +0.0% | +0.6% | -0.7% | -1.7% | — |
| Aug 14, 2023 | TNS | 0.39 | 0.52 | +33.3% | 26.90 | -1.4% | +1.0% | +0.0% | -0.3% | -2.1% | -1.7% | — |
| Mar 31, 2023 | BMO | — | -0.13 | — | — | — | — | — | — | — | — | — |
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 14 | Barclays | Maintains | Equal Weight → Equal Weight | — | $9.38 | $9.47 | +1.0% | +2.2% | +4.8% | +0.4% | +2.9% | +0.6% |
| Apr 8 | Evercore ISI | Maintains | Outperform → Outperform | — | $9.51 | $10.02 | +5.4% | +1.3% | -2.6% | -2.1% | +2.2% | +2.2% |
| Mar 9 | TD Cowen | Upgrade | Hold → Buy | — | $9.61 | $9.90 | +3.0% | +2.3% | -9.0% | +5.3% | -4.0% | -1.2% |
| Feb 27 | Baird | Maintains | Outperform → Outperform | — | $10.80 | $10.43 | -3.4% | -0.7% | -1.5% | -0.8% | -1.0% | -4.4% |
| Feb 27 | Barclays | Maintains | Equal Weight → Equal Weight | — | $10.80 | $10.43 | -3.4% | -0.7% | -1.5% | -0.8% | -1.0% | -4.4% |
| Jan 22 | TD Cowen | Maintains | Hold → Hold | — | $17.01 | $17.16 | +0.9% | +2.0% | -3.0% | +1.4% | +0.4% | -2.3% |
| Jan 8 | Truist | Upgrade | Hold → Buy | — | $17.49 | $18.25 | +4.3% | -0.3% | -0.3% | +5.8% | -5.6% | -3.5% |
| Jan 6 | Evercore ISI | Upgrade | In Line → Outperform | — | $16.62 | $18.12 | +9.0% | +5.5% | -0.3% | -0.3% | -0.3% | +5.8% |
| Dec 18 | Mizuho | Maintains | Neutral → Neutral | — | $16.19 | $16.43 | +1.5% | +2.6% | +6.8% | -0.3% | +1.2% | -1.2% |
| Dec 15 | Barclays | Upgrade | Underweight → Equal Weight | — | $15.72 | $16.34 | +3.9% | +2.2% | -0.4% | +1.3% | +2.6% | +6.8% |
| Dec 11 | Citigroup | Upgrade | Neutral → Buy | — | $15.14 | $16.11 | +6.4% | +2.7% | +1.1% | +2.2% | -0.4% | +1.3% |
| Nov 6 | Barclays | Maintains | Underweight → Underweight | — | $11.95 | $11.84 | -0.9% | -7.8% | +2.1% | -0.6% | +5.5% | -3.8% |
| Oct 17 | Mizuho | Maintains | Neutral → Neutral | — | $9.52 | $9.29 | -2.4% | -0.7% | +10.3% | -0.3% | +1.3% | +2.7% |
| Oct 8 | Evercore ISI | Maintains | In Line → In Line | — | $9.31 | $9.79 | +5.2% | +8.8% | +6.1% | -10.0% | +1.4% | -2.7% |
| Oct 2 | Barclays | Maintains | Underweight → Underweight | — | $9.52 | $9.61 | +0.9% | +0.8% | -1.6% | +1.5% | -2.9% | +8.8% |
| Sep 9 | Jefferies | Maintains | Hold → Hold | — | $10.32 | $10.22 | -1.0% | -2.4% | -0.6% | +2.2% | -1.3% | +1.0% |
| Sep 3 | Baird | Maintains | Outperform → Outperform | — | $10.01 | $10.48 | +4.7% | +6.8% | -1.7% | +10.7% | -11.3% | -2.4% |
| Aug 8 | Evercore ISI | Maintains | In Line → In Line | — | $7.24 | $7.20 | -0.6% | -9.1% | -2.9% | +14.4% | +7.3% | +0.8% |
| Aug 7 | Barclays | Maintains | Underweight → Underweight | — | $6.58 | $6.88 | +4.6% | +10.0% | -9.1% | -2.9% | +14.4% | +7.3% |
| Aug 4 | Baird | Upgrade | Neutral → Outperform | — | $5.46 | $6.19 | +13.4% | +17.6% | +2.2% | +0.3% | +10.0% | -9.1% |
| Jul 11 | Mizuho | Maintains | Neutral → Neutral | — | $5.27 | $5.15 | -2.3% | -3.0% | -2.0% | -5.8% | +3.8% | +1.0% |
| Jul 9 | Evercore ISI | Maintains | In Line → In Line | — | $4.79 | $4.87 | +1.7% | +5.2% | +4.6% | -3.0% | -2.0% | -5.8% |
| May 14 | Mizuho | Maintains | Neutral → Neutral | — | $5.00 | $4.90 | -2.0% | -4.4% | -0.6% | -6.5% | +0.2% | +5.4% |
| May 14 | Goldman Sachs | Maintains | Neutral → Neutral | — | $5.00 | $4.90 | -2.0% | -4.4% | -0.6% | -6.5% | +0.2% | +5.4% |
| May 13 | Barclays | Maintains | Underweight → Underweight | — | $5.19 | $5.26 | +1.3% | -3.7% | -4.4% | -0.6% | -6.5% | +0.2% |
| Apr 10 | Barclays | Downgrade | Equal Weight → Underweight | — | $6.45 | $6.05 | -6.2% | -19.2% | -0.6% | +3.5% | -9.3% | +3.3% |
| Apr 9 | Mizuho | Maintains | Neutral → Neutral | — | $5.70 | $5.64 | -1.1% | +13.2% | -19.2% | -0.6% | +3.5% | -9.3% |
| Mar 4 | Goldman Sachs | Maintains | Neutral → Neutral | — | $10.38 | $10.30 | -0.8% | +5.6% | -0.6% | -1.8% | -0.1% | -4.2% |
| Mar 4 | Evercore ISI | Maintains | In Line → In Line | — | $10.38 | $10.30 | -0.8% | +5.6% | -0.6% | -1.8% | -0.1% | -4.2% |
| Mar 4 | William Blair | Maintains | Market Perform → Market Perform | — | $10.38 | $10.30 | -0.8% | +5.6% | -0.6% | -1.8% | -0.1% | -4.2% |
| Mar 4 | Barclays | Maintains | Equal Weight → Equal Weight | — | $10.38 | $10.30 | -0.8% | +5.6% | -0.6% | -1.8% | -0.1% | -4.2% |
| Dec 11 | Citigroup | Downgrade | Buy → Neutral | — | $21.15 | $20.08 | -5.1% | -8.0% | +4.2% | -1.3% | +1.6% | -2.6% |
| Dec 6 | Baird | Downgrade | Outperform → Neutral | — | $23.57 | $22.94 | -2.7% | -8.1% | +4.0% | -6.1% | -8.0% | +4.2% |
| Nov 25 | Baird | Maintains | Outperform → Outperform | — | $19.73 | $20.20 | +2.4% | +5.9% | -1.0% | +4.2% | -2.3% | +3.3% |
| Nov 11 | Barclays | Maintains | Equal Weight → Equal Weight | — | $23.50 | $24.48 | +4.2% | -3.2% | -3.5% | -3.1% | -5.1% | -4.3% |
| Nov 11 | TD Cowen | Maintains | Hold → Hold | — | $23.50 | $24.48 | +4.2% | -3.2% | -3.5% | -3.1% | -5.1% | -4.3% |
| Nov 11 | Baird | Maintains | Outperform → Outperform | — | $23.50 | $24.48 | +4.2% | -3.2% | -3.5% | -3.1% | -5.1% | -4.3% |
| Oct 15 | Barclays | Maintains | Equal Weight → Equal Weight | — | $18.43 | $18.35 | -0.4% | +2.9% | +3.2% | -0.9% | +2.5% | -4.8% |
| Oct 8 | Evercore ISI | Maintains | In Line → In Line | — | $18.45 | $18.31 | -0.8% | +1.2% | +2.6% | -2.7% | +1.6% | -2.6% |
| Oct 8 | Goldman Sachs | Maintains | Neutral → Neutral | — | $18.45 | $18.31 | -0.8% | +1.2% | +2.6% | -2.7% | +1.6% | -2.6% |
| Sep 25 | Jefferies | Downgrade | Buy → Hold | — | $22.21 | $21.47 | -3.3% | -12.3% | +1.6% | +0.2% | +0.8% | -1.8% |
| Aug 20 | Deutsche Bank | Maintains | Hold → Hold | — | $22.39 | $22.15 | -1.1% | +0.1% | -1.2% | -3.3% | +2.9% | +2.0% |
| Aug 13 | BofA Securities | Maintains | Underperform → Underperform | — | $20.04 | $20.14 | +0.5% | +10.9% | +4.4% | -3.4% | -0.6% | +0.5% |
| Aug 13 | Citigroup | Maintains | Buy → Buy | — | $20.04 | $20.14 | +0.5% | +10.9% | +4.4% | -3.4% | -0.6% | +0.5% |
| Aug 13 | Evercore ISI | Maintains | In Line → In Line | — | $20.04 | $20.14 | +0.5% | +10.9% | +4.4% | -3.4% | -0.6% | +0.5% |
| Aug 13 | Baird | Maintains | Outperform → Outperform | — | $20.04 | $20.14 | +0.5% | +10.9% | +4.4% | -3.4% | -0.6% | +0.5% |
| Aug 13 | Barclays | Maintains | Equal Weight → Equal Weight | — | $20.04 | $20.14 | +0.5% | +10.9% | +4.4% | -3.4% | -0.6% | +0.5% |
| Aug 13 | TD Cowen | Maintains | Hold → Hold | — | $20.04 | $20.14 | +0.5% | +10.9% | +4.4% | -3.4% | -0.6% | +0.5% |
| Aug 8 | Evercore ISI | Downgrade | Outperform → In Line | — | $24.57 | $24.24 | -1.3% | +0.2% | +2.2% | -20.3% | +10.9% | +4.4% |
| Jul 18 | BofA Securities | Maintains | Underperform → Underperform | — | $26.97 | $26.70 | -1.0% | -4.2% | +0.7% | +3.0% | -3.7% | -1.1% |
| Date | Insider | Title | Type | Shares | Price | Value | Owned After | D1% | D5% |
|---|---|---|---|---|---|---|---|---|---|
| Jun 10, 2026 | Morais Mark A.Off | Chief Operating Officer | Sell | 4,674 | $16.82 | $79K | 71,365 | +0.91% | — |
| Jun 2, 2026 | Mcconnell Jill G.Off | Chief Financial Officer | Sell | 4,866 | $15.49 | $75K | 78,416 | +10.36% | -3.20% |
| Jun 2, 2026 | Morais Mark A.Off | Chief Operating Officer | Sell | 4,866 | $15.49 | $75K | 76,039 | +10.36% | -3.20% |
| May 18, 2026 | Parks RobertOff | Chief Accounting Officer | Sell | 2,000 | $13.44 | $27K | 20,389 | -4.09% | +11.77% |
8-K
Fortrea Holdings Inc. -- 8-K Filing
Jun 12
8-K · 2.02
!! High
Fortrea Holdings Inc. -- 8-K 2.02: Earnings Results
Fortrea Holdings reported quarterly earnings results, with detailed financial performance metrics available in the furnished press release for investor review and analysis.
May 5
8-K
Fortrea Holdings Inc. -- 8-K Filing
Fortrea Holdings (FTRE) reversed a weak first half of 2025 with strong fourth-quarter results and improved book-to-bills in the second half, signaling operational momentum heading into 2026.
Feb 26
Institutional (13F) — Top 20
All ↗
| # | Manager | Shares | Value | Chg | Period |
|---|---|---|---|---|---|
| 1 | Morgan Stanley | 4,935,250 | $85M | Reduced | Dec 2025 |
| 2 | Vanguard Capital Management Llc | 4,038,562 | $38M | New | Mar 2026 |
| 3 | Vanguard Portfolio Management Llc | 3,696,749 | $35M | New | Mar 2026 |
| 4 | Aqr Capital Management Llc | 3,298,421 | $31M | Added | Mar 2026 |
| 5 | Park West Asset Management Llc | 2,257,324 | $21M | Added | Mar 2026 |
| 6 | Longaeva Partners L.p. | 2,046,727 | $19M | Added | Mar 2026 |
| 7 | Renaissance Technologies Llc | 1,432,709 | $13M | Added | Mar 2026 |
| 8 | Fmr Llc | 1,244,137 | $12M | Reduced | Mar 2026 |
| 9 | Algert Global Llc | 1,138,584 | $11M | Added | Mar 2026 |
| 10 | Nuveen, Llc | 1,075,256 | $10M | Reduced | Mar 2026 |
| 11 | Northern Trust Corp | 1,000,286 | $9M | Added | Mar 2026 |
| 12 | Jpmorgan Chase & Co | 1,010,361 | $9M | Added | Mar 2026 |
| 13 | Beck Mack & Oliver Llc | 947,748 | $9M | Added | Mar 2026 |
| 14 | Principal Financial Group Inc | 483,223 | $8M | Reduced | Dec 2025 |
| 15 | Lord, Abbett & Co. Llc | 826,519 | $8M | Added | Mar 2026 |
| 16 | Bnp Paribas Financial Markets | 818,384 | $8M | Added | Mar 2026 |
| 17 | Invesco Ltd. | 719,572 | $7M | Reduced | Mar 2026 |
| 18 | Citigroup Inc | 349,771 | $6M | Added | Dec 2025 |
| 19 | Ubs Group Ag | 578,536 | $5M | Added | Mar 2026 |
| 20 | Bank Of New York Mellon Corp | 563,269 | $5M | Reduced | Mar 2026 |
Mutual Funds / ETFs (N-PORT) — Top 20
All ↗
Valuation
Market Cap
$1.40B
Enterprise Value
$1.28B
P/E (TTM)
-1.42x
Forward P/E
22.61x
PEG Ratio
-0.01x
P/B
2.48x
P/S
0.51x
P/FCF
15.81x
EV/EBITDA
—
Shares Out
91.2M
Financials (TTM)
Revenue
$2.72B
Net Income
-$986.2M
EBITDA
-$813.6M
Free Cash Flow
$88.3M
Op Cash Flow
$113.5M
EPS Basic
$-10.81
EPS Diluted
$-10.81
EPS Forward
$0.68
Gross Margin
15.6%
Op Margin
-1.1%
Net Margin
-36.2%
Balance Sheet
Total Assets
$2.72B
Total Liab.
$2.15B
Total Equity
$563.5M
Cash
$174.6M
LT Debt
$54.0M
Book Value/Sh
$6.18
Debt/Equity
0.12x
Current Ratio
0.98
Quick Ratio
0.98
Returns & Growth
ROE
-175.0%
ROA
-36.3%
ROIC
-1.7%
Rev Growth YoY
+1.0%
EPS Growth YoY
-194.6%
Price Returns
2W
+8.1%
1M
+33.8%
3M
+43.6%
6M
+21.1%
12M
+257.9%
Technicals
52W High
$18.40
52W Low
$4.45
50d MA
$13.41
200d MA
$12.45
RSI (14)
49.50
ATR (14)
$1.06
Beta
1.77
Avg Volume
1.3M
Dividends
Div Rate
$0.00
Div Yield
—
Frequency
—
Ex-Div Date
—
Analyst Price Targets
Consensus
$18.83
High
$25.00
Low
$11.00
Median
$20.00
Data updated apr 25, 2026 10:17am
· Source: financialmodelingprep.com